Posted on: September 11, 2024October 3, 2024

Maven Bioscience Launches KindRx, a Revolutionary Pet and Veterinary Product Line

June 2024 – Maven Bioscience has announced the launch of KindRx, a new division dedicated to creating cutting-edge pet and veterinary products. After years of working behind the scenes producing white-label pet products, the company is now making its mark on the global market with the introduction of the world’s most advanced line of pet and veterinary solutions.

KindRx products are designed for both everyday pet owners and veterinary professionals, offering a range of innovative formulations aimed at improving animal health and wellness. With this global launch, Maven Bioscience is positioning KindRx as a leader in the field, providing high-quality, science-backed solutions for pets.

“KindRx represents the culmination of years of research and development,” said a Maven Bioscience spokesperson. “We’re proud to bring our expertise from the pharmaceutical and precision medicine fields into the pet care industry, delivering products that will set a new standard for pet wellness.”

With this bold move, Maven Bioscience aims to transform the pet care landscape by offering specialized products that blend scientific precision with practical, user-friendly applications for both pet owners and veterinary experts.

Posted on: September 11, 2024September 11, 2024

Maven Hemp Rebrands as Maven Bioscience, Signaling Shift to Precision Medicine

February 2024 – Maven Hemp, a leading player in the CBD industry, has officially rebranded as Maven Bioscience, marking its expanded focus into the field of pharmaceutical medicine and clinical testing. The company, previously known for its hemp-derived products, is now positioning itself as a global leader in precision medicine.

“We are not just a CBD company,” CEO and Founder, Zev Barnett explained. “We have worked, and continue to work, with top doctors and researchers from around the world to develop the best products for you.”

The name change reflects Maven Bioscience’s growing involvement in personalized healthcare. The company is pioneering products tailored to individual DNA profiles- with their groundbreaking DNA-matched formulas. These personalized treatments utilize data from either Endo-DNA genetic testing kits or customers’ existing genetic data from popular services such as 23andMe or AncestryDNA.

By analyzing an individual’s unique genetic profile, Maven Bioscience aims to offer more effective, personalized treatments that deliver optimal results. The move signals the company’s commitment to innovation in the burgeoning field of precision medicine, ensuring that their products meet the needs of consumers in the most targeted way possible.

With this shift, Maven Bioscience is carving out a distinctive niche in the healthcare landscape, blending the power of genetics with pharmaceutical expertise.

Posted on: January 31, 2023September 16, 2024

4th Cannamerica Event in Quito, Ecuador 2023

Event Name: 4th Cannamerica Event in Quito, Ecuador 2023
Date: Feb 9-11 2023

Maven is proud to be the Cannabis Cotopaxi Sponsor of the 4th Cannamerica Event in Quito, Ecuador, Feb 9-11 2023

Cannamerica is featuring “Cannabis from multiple and new perspectives” including Master Lectures and Scientific Work from over 30 international expert speakers on phytocannabinoids

Maven Hemp’s CEO, Zev Barnett, will join over 30 other international speakers presenting talks sharing their insights and he will be focusing on how innovation is changing cannabis science in the animal and pet care industries.

Posted on: August 30, 2022September 16, 2024

LATAM Conference in Panama 2022

Event Name: LATAM Conference in Panama 2022
Date: September 1 & 2, 2022

Maven Hemp is proud to be a gold sponsor for the 2022 LATAM CANN BIZ conference in Panama City, Panama.

LATAM CANN BIZ is an interdisciplinary conference focusing on global and regional industry trends and up-to-date information on emerging regulatory frameworks, technology, science, and best agricultural and production practices in the cannabis industry.

Maven Hemp’s CEO, Zev Barnett, will join over 40 other international speakers presenting talks sharing their insights and focusing on how to be successful in the cannabis industry.

Posted on: August 28, 2022June 12, 2024

CVDC- Congreso Veterinario de Colombia 2022

Event Name: CVDC- Congreso Veterinario de Colombia
Date: August 2, 2022

Maven Hemp was a proud sponsor of the pre-conference seminar on cannabinoids in science and small animals at CVDC- Congreso Veterinario de Colombia on August 2, 2022

With over 1200 veterinarians in attendance, this is a leading event for veterinary science in Colombia and beyond. Participants came from Uruguay, Mexico and several other countries.

Posted on: January 10, 2022June 12, 2024

Holistic Virtual Physical Therapy Program Partnership

Maven Hemp, a Denver, Colorado based premiere CBD and Cannabinoid product manufacturer with a mission to change the face of medicine is proud to announce a partnership that takes another step in making their mission a reality for people around the world.

Maven has partnered with Denver-based Symfit Physical Therapy & Fitness, who specializes in video-on-demand (VOD) and virtual physical therapy options and is the winner of WebPT’s 2020 award for the most innovative physical therapy practice at their annual Ascend conference.

Maven and Symfit together have launched a virtual physical therapy program that combines healthy posture and sleep strategies along with mindfulness exercise with Maven’s cannabinoid-based products to help people fix themselves that can be done in the privacy of their own home, office, or anywhere.

Programs for a healthy neck, shoulders, lower back, hips, and knees are all offered.

“With this partnership, we have the opportunity to provide patients best-in-class care along with premium grade CBD and Cannabinoid-based products in the comfort of their own home at a cost that is typically less than out-of-pocket insurance. It is truly a step forward in changing medicine and we’re grateful to be leading the charge in this initiative” says Maven Hemp CEO Zev Barnett.

Posted on: January 7, 2022June 12, 2024

Maven Hemp Releases Radicle ACES Summary of Key Findings: Significant Improvement

People taking Maven 2500mg Total Hemp Extract Tincture saw significant improvement in well-being, anxiety, sleep quality, and pain throughout the study period.

Maven Hemp, a manufacturer and distributor of premium CBD and Cannabinoid products on a mission to supply the world with unique, impact-driven, regenerative hemp-based products and leading insights, has released the results of the Radicle ACES Brand Insight Report on its Maven Total Hemp Extract Tincture. Maven Hemp recently participated in the groundbreaking Radicle ACES (Advancing CBD Education and Science) study, which was the largest and most comprehensive randomized controlled trial of its kind.

Over the course of four weeks, the rigorous study tracked consumption and effectiveness of orally ingested CBD products across a diverse population of nearly 3,000 participants and 13 brands, and assessed well-being, quality of life, longer-term pain, sleep quality, and feelings of anxiety using validated, standardized health indices.

Key findings show that study participants assigned to the Maven 2500mg Total Hemp Extract Tincture reported a 72 percent improvement in well-being, as assessed by the World Health Organization (WHO)-5 Well Being Index; a 54 percent decrease in anxiety, measured using the Generalized Anxiety Disorder (GAD)-7 scale; a 33 percent improvement in sleep quality, measured using the Patient-Reported Outcomes Measurement Information System (PROMIS™) Sleep Disturbance SF 8B scale; and a 26 percent decrease in pain, which was measured using the PEG-3 Scale. Participants experienced the largest improvements during the first week of use, with noticeable effect most often within one hour of taking the product.

“The ACES study was driven by our deep commitment to contribute to the body of scientific data in the CBD market,” stated Pelin Thorogood, Co-founder and Executive Chair of Radicle Science. “This rigorous study provides objective health outcome data for a variety of common health conditions, with the potential to offer unprecedented guidance on CBD effectiveness based on demographic or behavioral differences.”

To learn more about Maven Hemp, please visit mavenhemp.com. And, for more background on Radicle ACES methodology and additional insights from collaborators and experts involved in the study, see this Radicle Resources article.

About Maven Hemp

We’re on a mission to supply you with unique, impact-driven, regenerative hemp-based products and leading insights. The hemp and cannabis ecosystem can experience volatility without a strong data-driven foundation. Our team at Maven is acting on a resiliency-focused opportunity to create lasting vitality by:

Participating in the standardization of CBD medical treatments for people around the globe by implementing impact data, ESG metrics, and industry-leading research in a holistic and integrative way.
Focusing on transparency and a secure chain of custody to substantiate the quality of our products and gain the confidence of our customers.
Increasing our growth by making a positive impact on the communities, people, and ecological landscape our business influences, while engaging our stakeholders.

Follow Maven Hemp on LinkedIn.

About Radicle Science

Radicle Science is a transformative healthtech B-corp offering the first ever scalable path to validate and predict the health effects of nonprescription consumer products, transforming them into democratized precision solutions for ailments or enhancement of human function. Radicle Science leverages a proprietary data analytics platform and a virtual, direct-to-consumer (D2C) clinical trial model to deliver objective health outcome data across diverse populations and conditions, at a fraction of the cost and time of traditional methods. Our Radicle Vision is a future where affordable, accessible, consumer health products are trusted by patients, recommended by healthcare providers, reimbursed by insurance, and used as widely as pharmaceutical drugs.

To learn more, please visit www.radiclescience.com and follow their LinkedIn page and Twitter page.

Posted on: January 5, 2022June 12, 2024

Personalized Cannabis is a thing? YES!

Are you an ultra-metabolizer of CBD but an intermediate metabolizer of THC?

Back in the “old days”, cannabis dosage was left to trial and error by the user. Lots and lots of experimentation with varying degrees of success. As even the most casual user of cannabis products knows, every person is different when it comes to tolerance levels and what works best for their particular situation.

The advancement of cannabis science has come a long way, and now anyone can benefit from the healing powers of “personalized cannabis” with a DNA test from EndoDNA, the most comprehensive endocannabinoid DNA test available today.

Len May, CEO and Co-founder of Endo-Canna Health (parent company of EndoDNA) and author of the book Making Cannabis Personal sat down on the podcast BUDDING INTERESTS and spoke with host Zev Barnett (available here: https://tinyurl.com/LenMay ) and gave the lowdown on this game changing innovation in the cannabis-as-medicine movement.

All a person has to do is go to EndoDNA.com and either order one of their EndoDNA kits or upload their raw digital DNA report from 23 and Me or Ancestry.com to get a free immune function Genetics report.

The EndoDNA test analyzes more than 600,000 SNPs (Single Nucleotide Polymorphisms, pronounced “SNIPS”) related to your endocannabinoid system. These specific SNPs exhibit genetic variations which have been shown in academic research to be associated with specific medical conditions, mental wellness and physical health.

Information gleaned from this report is then used to help you optimize your cannabinoid and CBD experience in a number of ways, including:

Learn the most ideal ratios, methods and dosing for your body.
Know which terpenes and cannabinoids to see out and which to avoid.
Understand any risks or benefits from using cannabinoids for your specific genotype.
Identify the specific cannabinoid formulations most aligned with your genetics.

EndoDNA then will make formulation suggestions for your specific genetics as well as provide a product marketplace where you can find Endo-Aligned Trusted formulations and a product geolocator to help you find those products in your area.

Tune into BUDDING INTERESTS to learn more about EndoDNA and how to personalize your cannabis consumption. All BUDDING INTERESTS listeners get 25% off both the full EndoDNA test and raw data uploads. See the podcast description for the discount code.

Posted on: August 6, 2021June 12, 2024

Radicle Science Launches Study to Determine Effectiveness of CBD Products

Featuring Parker, Colorado-based CBD company Maven Hemp

The 3,000 participant study will capture and publish the most comprehensive data ever collected on CBD product effectiveness from 13 commercially available U.S. brands, including Maven Hemp.

Radicle Science, a transformative healthtech B-corp validating natural products for the first time, announces the launch of the Radicle ACES (Advancing CBD Education and Science) study.

Using a virtual, direct to consumer (D2C) approach, Radicle ACES is the largest and most comprehensive randomized controlled trial (RCT) of its kind, collecting data on thirteen mission-driven U.S. CBD brands, featuring Maven Hemp alongside ALTWELL, Charlotte’s Web, Columbia Care, Healer, Lord Jones, MD FARMA, Peels (a citrus-derived brand), Prospect Farms, PURAURA Naturals from Enhanced Botanicals, Rae Wellness, Trokie, and Verséa Wellness.

“We believe in the importance of having access to verified data that supports the ways our company makes a positive impact. Participating in the Radicle ACES study allows us to align with Radicle, a B-Corp that shares our values, while building trust and confidence as we work to distribute our products to doctors and patients across The Americas and beyond. We’re also in the process of B-Corp certification, and are making progress towards our impact goals every day. We’re proud to align with mission-driven partners, including Radicle Science and the other 12 brands in the Radicle ACES study.” – Zev Barnett, Founder and CEO of Maven Hemp

Radicle ACES is Institutional Review Board (IRB) approved and will capture CBD effectiveness data directly from 3,000 study participants. During the four-week study, participants will use the Radicle Science platform to track consumption and effectiveness of orally ingested CBD products on well-being, quality of life, pain, sleep disturbance, and anxiety.

Radicle ACES will use validated, standardized health indices to gather health outcome data from a diverse population across a variety of ethnicities, age groups, geographies, behavioral habits, and pre-existing health conditions.

“We’re applying science to understand the effectiveness of CBD products used by tens of millions of Americans every day,” said Jeff Chen, MD/MBA, Co-founder and CEO of Radicle Science.

Academic collaborators include Miroslav Backonja, MD (Clinical Professor, University of
Washington), Chris Colwell, PhD (Professor, UCLA), Derek Loewy, PhD (Director of Behavioral Sleep Medicine at Scripps Clinic Sleep Center), Ethan Russo, MD (Founder and CEO of CReDO Science), Kate Taylor, PhD (Associate Professor, UCLA), Jill Waalen, MD/MPH (Co-Director of Biostatistics at Scripps Research), and more.

The Real World Evidence (RWE) collected will inform scientific understanding on dosing, usage patterns, user characteristics, effectiveness across conditions, and predictors and modifiers of treatment response.

“The Radicle ACES study aims to answer lingering questions as to who should take cannabidiol, how much and for what conditions, as well as differing dosage patterns,” said Ethan Russo, MD, Scientific Expert for Radicle Science, and Founder and CEO of CReDO Science. “CBD is much more subtle in its effects and quite benign compared to THC. Patients are unclear on what product to choose and healthcare providers don’t yet have the data to counsel on proper dosage.”

For Maven Hemp, sharing data and answers from the Radicle ACES study will solidify the company’s ability to create positive impact across the local Colorado hemp production and consumption ecosystem. Alongside the company’s physician partners across the globe, as a custom product manufacturer, Maven Hemp aims to support the realization of improved patient outcomes.

Anonymized aggregate results will be released in October 2021. For more background on Radicle ACES methodology and additional insights from collaborators and experts involved in the study, see these Radicle Resources articles.

Follow Maven Hemp on LinkedIn and Instagram to stay updated on the Radicle ACES study as well as new product offerings. Visit the Maven Hemp website to browse through current products and engage with the company’s efforts to realize positive economic, social and environmental impact locally and internationally.

Posted on: December 19, 2019June 12, 2024

The Difference between CBD Isolate, THC-Free and Full Spectrum Products

Differences in Cannabis Oil Products

Cannabidiol is one of hundreds of chemicals produced by the cannabis plant. Together, these groups of chemicals are called cannabinoids (or phytocannabinoids if you want to be specific about the fact that they are from a plant). These are usually extracted as something called cannabis oil (oftentimes misspelled as “canibus oil” or “cannabus oil”). Products made from this oil often have different labels based on the purity of the extract, and the level of THC content. In this article, we’ll take a look at some of the most common hemp extract labels that you’ll run into when purchasing CBD hemp oil.

CBD Isolate

While it does take more work, CBD can be isolated from the extract and this is labeled as “CBD Isolate” or “Isolate CBD”. These kinds of products don’t contain any other cannabinoids, terpenes, flavonoids, and other plant chemicals. This is achieved by a stringent purification process that begins by extracting the oil from high-CBD hemp plants. From there, the oil is refined to remove contaminants, then distilled to concentrate the CBD to approximately 80%. Chromatography purifies the CBD from the distillate and then that substance is crystallized to yield a 99% pure CBD powder.

When shopping for CD isolates, it’s a good idea to make sure that the product has been tested by a third-party lab to ensure purity. Maven Hemp CBD isolate is tested and retested throughout the process to ensure purity.

Zero-THC Oil

A zero-THC label means that the hemp extract contains the full spectrum of the plant including the other phytocannabinoids but doesn’t contain any THC. THC stands for tetrahydrocannabinol and is the only psychoactive cannabinoid. Cannabidiol and the other chemicals do not. For people who want the benefits of a broader spectrum of the cannabis plant, opting for a zero-THC product may be the way to go, in comparison to the CBD isolate.

Full-Spectrum CBD

When it comes to full-spectrum products, it’s important to remember that the legal hemp plant still contains 0.3% THC or less. Since plants are living organisms, it’s difficult to predict the exact amount of THC a hemp plant will produce. [1] BeyondTHC, the hemp plant contains hundreds of other compounds, such as terpenes, flavonoids, lipids, omega 3 acids, and omega 6 acids, which are beneficial for anti-inflammatory effects. Ingesting the full spectrum of the hemp plant is the optimal way to support the endocannabinoid system.

Is 0.3% THC a lot?

Hemp products have less than .3% THC. A typical dispensary product could have 15%-100% more THC. Important to read labels to not be misled.

Delivery Method of CBD

Finally, the delivery method that you choose to use will affect how much time it takes before you feel the effects. Using an inhaler is the fastest method because the CBD is directly absorbed into your bloodstream through your lungs. Eating or using a tincture takes longer because your mouth and gastrointestinal tract must first absorb the CBD. And remember, CBD loves oils and hates water, so it’s a good idea to eat or use CBD oils with other oily/high-fat foods such as avocados, milk, or ice cream.

Always Check the Label!

Next time you’re out shopping for CBD products, remember to check the label for what kind of hemp extract it contains. Also make sure to check to see if the product has been tested, verified, and certified by a third-party testing lab. To get the best experience from using CBD, it’s important that high-quality products are used.

At Maven, we curate only the highest-quality raw materials in America to create our CBD products. You can also be confident that our products are pure and contain what they say they contain. How? Because every single product we provide is Lab-Tested by an independent third-party lab and produced using Good Manufacturing Practices (GMP).

References

Jikomes, N., & Zoorob, M. (2018). The Cannabinoid Content of Legal Cannabis in Washington State Varies Systematically Across Testing Facilities and Popular Consumer Products. Scientific reports, 8(1), 4519. doi:10.1038/s41598-018-22755-2